Abnormal kainate receptor expression in prefrontal cortex in schizophrenia

Neuropsychopharmacology

Volumn 24, Issue 5, 2001, Pages 545-552

  Meador Woodruff, James H ^a   Davis, Kenneth L ^b   Haroutunian, Vahram ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamate; In situ hybridization; Ionotropic glutamate receptors; Prefrontal cortex; Receptor autoradiography; Striatum

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 5; GLUTAMATE RECEPTOR 6; GLUTAMATE RECEPTOR 7; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR 1; KAINIC ACID RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SCHIZOPHRENIA; STOICHIOMETRY;

AGED; AGED, 80 AND OVER; BRAIN CHEMISTRY; FEMALE; GLUTAMIC ACID; HUMANS; KAINIC ACID; MALE; NEURONS; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RECEPTORS, KAINIC ACID; RNA, MESSENGER; SCHIZOPHRENIA; TRITIUM;

EID: 0035078317     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00189-5     Document Type: Article

References (32)

1. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers
2. Schizophrenia: A subcortical neurotransmitter imbalance syndrome?
3. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
4. The effect of chronic haloperidol on glutamate receptor subunit (gluR1, gluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain
5. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA
6. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
7. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
8. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
9. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum
10. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
11. Cloned glutamate receptors
12. Effect of phencyclidine in chronic schizophrenia
13. Recent advances in the phencyclidine model of schizophrenia
14. Amelioration of negative symptoms in schizophrenia by glycine
15. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
16. Subanesthetic effects of the noncompetitive NMDA antagonist ketamine in humans: Psychotomimetic perceptual cognitive and neuroendocrine responses
17. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
18. Kainate receptors: An interplay between excitatory and inhibitory synapses
19. Model psychoses and schizophrenia
20. Dopamine receptor transcript expression in striatum prefrontal and occipital cortex: Focal abnormalities in orbitofrontal cortex in schizophrenia
21. Glutamate receptor expression in schizophrenic brain
22. 3H]kainic acid binding in the prefrontal cortex in schizophrenia
23. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains
24. RNA editing of human kainate receptor subunits
25. RNA editing of the glutamate receptor subunits gluR2 and gluR6 in human brain tissue
26. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal gluR6 and KA2 transcripts in schizophrenia
27. Rat gluR7 and a carboxy-terminal splice variant, gluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate
28. The role of RNA editing in controlling glutamate receptor channel properties
29. Expression of NMDAR1, gluR1, gluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
30. Effect of RNA editing and subunit co-assembly on single-channel properties of recombinant kainate receptors
31. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics
32. Activation and desensitization of hippocampal kainate receptors